Mallinckrodt Presents Data on TERLIVAZ® (terlipressin) for Injection in Patients with Hepatorenal Syndrome (HRS) at the 2024 Digestive Disease Week® (DDW) ...Middle East

– Two poster presentations of Mallinckrodt's research for adults with HRS with rapid reduction in kidney function1 provide further insight into treatment with TERLIVAZ for appropriate patients – DUBLIN, May 18, 2024 /PRNewswire/ -- Mallinckrodt plc, a global specialty pharmaceutical...

Hence then, the article about mallinckrodt presents data on terlivaz terlipressin for injection in patients with hepatorenal syndrome hrs at the 2024 digestive disease week ddw was published today ( Saturday 18/05/2024 - 02:00 PM ) and is available on PR Newswire ( Middle East ) The editorial team at PressBee has edited and verified it, and it may have been modified, fully republished, or quoted. You can read and follow the updates of this news or article from its original source.

Read More Details
Finally We wish PressBee provided you with enough information of ( Mallinckrodt Presents Data on TERLIVAZ® (terlipressin) for Injection in Patients with Hepatorenal Syndrome (HRS) at the 2024 Digestive Disease Week® (DDW) )

Also on site :

• Philippines volcano erupts, blanketing ash across the sky
• 1970 Soft Rock Classic, That Became a Career-Defining Song for ’70s Legend, Ranked Among ‘Greatest Songs of All Time’
• Aldi's Boho Accent Table Is a Small Space Game Changer